Monitoring Response to Primary Chemotherapy in Breast Cancer using Dynamic Contrast-enhanced Magnetic Resonance Imaging

Laura Martincich(Candiolo Cancer Institute), Filippo Montemurro(Candiolo Cancer Institute), Gaetano De Rosa(Candiolo Cancer Institute), Vincenzo Marra(Candiolo Cancer Institute), Riccardo Ponzone(Candiolo Cancer Institute), Stefano Cirillo(Candiolo Cancer Institute), Marco Gatti(Candiolo Cancer Institute), Nicoletta Biglia(Candiolo Cancer Institute), Ivana Sarotto(Candiolo Cancer Institute), P Sismondi(Candiolo Cancer Institute), Daniele Regge(Candiolo Cancer Institute), Massimo Aglietta(Candiolo Cancer Institute)
Breast Cancer Research and Treatment
January 1, 2004
10.1023/b:brea.0000010700.11092.f4
Cited by 241

Abstract

Related Papers

Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusable tracer: Standardized quantities and symbols
Paul S. Tofts, Gunnar Brix, David L. Buckley et al.|Journal of Magnetic Resonance Imaging|1999|3.1k
Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
Henry M. Kuerer, Lisa A. Newman, Terry L. Smith et al.|Journal of Clinical Oncology|1999|1.3k
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.
G. Bonadonna, Pinuccia Valagussa, Cristina Brambilla et al.|Journal of Clinical Oncology|1998|567
Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy
Gabriel N. Hortobágyi, Frederick C. Ames, Aman U. Buzdar et al.|Cancer|1988|508
Pathophysiologic basis of contrast enhancement in breast tumors
Michael V. Knopp, Elisa K. Weiß, Hans‐Peter Sinn et al.|Journal of Magnetic Resonance Imaging|1999|406